All News #Library
Biotech
R1 Therapeutics Raises $77.5M Series A for Hyperphosphatemia
17 Mar 2026 //
GLOBENEWSWIRE
Alebund Unveils AP301 Phase 3 Trial Results at ASN 2025 Congress
07 Nov 2025 //
PR NEWSWIRE

Market Place
Sourcing Support